Chartwell Actives was established in 2016 as a Portuguese division of Chartwell Actives LLC. Our intent is to become a value-added global (niche) player in the APIs business with a strong integration with Chartwell Pharmaceuticals and the US as our target market. We are leveraging the expertise of our team of seasoned industry professionals with decades of experience in GMPs applied to API Manufacturing (US FDA / EU EDQM) to together with Chartwell Pharma, offer full support covering the whole product development and market introduction (US and EU among others) cycle to our clients.
We are building our business through a combination of smart acquisitions and key partnerships, including co-developments and tech transfers.
This will provide Chartwell Actives with the key resources to do business in the three following areas:
-Contract Development and Manufacturing
-Own production site(s) and portfolio of high value APIs